James Hambro & Partners LLP Lowers Stock Holdings in Danaher Corporation $DHR

James Hambro & Partners LLP lessened its stake in shares of Danaher Corporation (NYSE:DHR) by 48.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 150,904 shares of the conglomerate’s stock after selling 142,057 shares during the quarter. Danaher comprises approximately 1.1% of James Hambro & Partners LLP’s portfolio, making the stock its 21st biggest position. James Hambro & Partners LLP’s holdings in Danaher were worth $29,893,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. WFA of San Diego LLC purchased a new stake in shares of Danaher in the second quarter valued at about $26,000. Howard Hughes Medical Institute purchased a new stake in Danaher in the 2nd quarter valued at approximately $27,000. Red Tortoise LLC raised its stake in shares of Danaher by 175.0% during the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after buying an additional 98 shares in the last quarter. Heartwood Wealth Advisors LLC acquired a new stake in shares of Danaher in the 3rd quarter valued at approximately $37,000. Finally, Ramirez Asset Management Inc. purchased a new stake in shares of Danaher in the second quarter valued at approximately $40,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Trading Up 1.3%

Shares of Danaher stock opened at $230.96 on Wednesday. The business has a 50 day moving average price of $221.32 and a 200 day moving average price of $207.61. The company has a market capitalization of $163.14 billion, a P/E ratio of 47.62, a P/E/G ratio of 4.42 and a beta of 0.89. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $258.23.

Danaher (NYSE:DHR) last released its quarterly earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share for the quarter, topping the consensus estimate of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The company had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. During the same quarter last year, the business posted $1.71 earnings per share. Danaher’s revenue was up 4.4% compared to the same quarter last year. Sell-side analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Friday, December 26th. Danaher’s dividend payout ratio is 26.39%.

Insider Transactions at Danaher

In other news, Director Teri List sold 3,298 shares of the business’s stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total value of $746,997.00. Following the completion of the transaction, the director owned 20,762 shares of the company’s stock, valued at $4,702,593. The trade was a 13.71% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Brian W. Ellis sold 21,776 shares of the company’s stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the transaction, the senior vice president directly owned 14,553 shares in the company, valued at $3,190,454.19. The trade was a 59.94% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 30,248 shares of company stock worth $6,609,663 over the last ninety days. 11.20% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on DHR shares. Weiss Ratings reissued a “hold (c)” rating on shares of Danaher in a report on Monday. Jefferies Financial Group raised their price objective on shares of Danaher from $245.00 to $255.00 and gave the company a “buy” rating in a research note on Wednesday, December 17th. Morgan Stanley assumed coverage on shares of Danaher in a report on Monday, December 1st. They issued an “overweight” rating and a $270.00 target price for the company. TD Cowen boosted their price target on Danaher from $250.00 to $260.00 and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. Finally, Royal Bank Of Canada set a $241.00 price target on Danaher in a report on Tuesday, September 2nd. Twenty-one investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $248.25.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.